5–10%
Sensitivity of iPLEX Pro
Micro Solutions / Life Science
MassARRAY chemistry set for genotyping from routine variants to mutations with a 0.1% share
MassARRAY chemistry set for genotyping from routine variants to mutations with a 0.1% share
Choice of chemistry by type of sample, panel and required sensitivity
MassARRAY reagent kits allow you to customize the platform for a wide range of tasks - from routine genotyping of inherited variants to highly sensitive search for somatic mutations and quantitative analysis of methylation.
iPLEX Pro is designed for multiplex analysis of germinal variants; iPLEX HS increases sensitivity for somatic variants with low allelic lobe; UltraSEEK uses mutant allele enrichment for even more sensitive analysis; EpiTYPER/MassCLEAVE is used after bisulfite conversion for quantitative profiling. Methylation: The reagent sets are presented as a single compatible ruler, and the specific set is selected by sample type, panel type and sensitivity required.
iPLEX Pro supports up to 40-plex analysis and is commonly used for variants with an allelic fraction of 5-10% or higher. iPLEX HS is designed to detect from about 1% VAF, and UltraSEEK - up to 0.1% VAF under validated conditions. The actual detection limit depends on the matrix, quality and quantity of DNA, panel composition and analytical validation. Agena ClearSEEK reagents are also available for current projects; these are included after confirming a compatible panel and an up-to-date catalog number.
Sensitivity of iPLEX Pro
sensitivity of iPLEX HS
sensitivity of UltraSEEK
chemistry
amplification and prolongation of the primer
determination of the mass of the reaction
| Limit of detection | 5–10% ≥1% ≥0,1% 5 % (change in methylation) |
|---|---|
| Markers for reactions | 40 15 15 — |
| Principle of reaction | all 4 nucleotides in equal concentration nucleotides in modified ratio, enrichment of mutant alleles only rare/mutant nucleotide Bisulfite conversion + MassCLEAVE cleavage |
| Types of specimens | blood, serum, buccal cells, microdissected and freshly frozen tumor cells, hair follicles, WGA DNA heterogeneous solid tumors, fine needle aspiration, seed mixtures circulating tumor and extracellular DNA from plasma — |
|---|---|
| Typical tasks | pharmacogenetics, hereditary diseases, validation of biomarkers, breeding, validation of culture strains somatic mutations, low-frequency variants, validation of NGS findings, screening for GMOs oncogenic markers of resistance and progression, non-invasive testing quantification |